<DOC>
	<DOCNO>NCT00804401</DOCNO>
	<brief_summary>Compare rate extent absorption two oral formulation Naproxen Tablets , administer 1 x 500 mg tablet fast condition .</brief_summary>
	<brief_title>Bioequivalence Study Between Two Oral Formulations Naproxen 500 mg Tablets Under Fasting Conditions</brief_title>
	<detailed_description />
	<mesh_term>Naproxen</mesh_term>
	<criteria>healthy men woman , nonsmoker , 18 year age old willing participate sign copy inform consent form clinically significant illness surgery within 4 week prior study dose body mass index great equal 30.0 recent history drug alcohol addiction abuse pregnant lactating woman history allergic response naproxen , NSAIDs , related drug , heparin history allergic reaction asthma , rhinitis , nasal polyp , urticaria , hypotension associate use aspirin NSAIDs history know presence gastrointestinal ulceration , bleed perforation use tobacco product within 6 month prior study dose evidence clinically significant disorder whose laboratory result deem clinically significant receipt drug part research study within 30 day prior study dose</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>bioequivalency</keyword>
	<keyword>Naproxen</keyword>
</DOC>